Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 132

1.

Can Bcl-XL expression predict the radio sensitivity of bilharzial-related squamous bladder carcinoma? A prospective comparative study.

Abdel Raheem AM, Hameed DA, ElGanainy EO, Mosad E, Abdelwanis ME, Kamel NA, Hammouda HM, Abdelaziz MA, Hemeyda K.

BMC Cancer. 2011 Jan 12;11:16. doi: 10.1186/1471-2407-11-16.

2.

Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic?

Hameed DA, Abdel Raheem AM, Mosad E, Hammouda HM, Kamel NA, Abdel Aziz MA.

Urology. 2008 Aug;72(2):374-8. doi: 10.1016/j.urology.2007.12.063. Epub 2008 Mar 17.

PMID:
18342927
3.
4.

Preoperative radiotherapy for muscle-invasive bladder carcinoma. Long term follow-up and prognostic factors for 338 patients.

Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC.

Cancer. 1994 Nov 15;74(10):2819-27.

6.

A prospective randomized trial for postoperative vs. preoperative adjuvant radiotherapy for muscle-invasive bladder cancer.

El-Monim HA, El-Baradie MM, Younis A, Ragab Y, Labib A, El-Attar I.

Urol Oncol. 2013 Apr;31(3):359-65. doi: 10.1016/j.urolonc.2011.01.008. Epub 2011 Feb 25.

PMID:
21353794
7.

Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder.

Youssef R, Kapur P, Shariat SF, Arendt T, Kabbani W, Mosbah A, Abol-Enein H, Ghoneim M, Lotan Y.

BJU Int. 2012 Oct;110(7):961-6. doi: 10.1111/j.1464-410X.2012.10949.x. Epub 2012 Feb 28.

8.

The value of clinical prognostic factors for survival in patients with invasive urinary bladder cancer.

Asadauskiene J, Aleknavicius E, Pipiriene-Zelviene T, Jankevicius F.

Medicina (Kaunas). 2010;46(5):305-14.

9.

Radical cystectomy with or without adjuvant polychemotherapy for non-organ-confined transitional cell carcinoma of the urinary bladder: prognostic impact of lymph node involvement.

Stöckle M, Wellek S, Meyenburg W, Voges GE, Fischer U, Gertenbach U, Thüroff JW, Huber C, Hohenfellner R.

Urology. 1996 Dec;48(6):868-75.

PMID:
8973669
10.

Squamous cell carcinoma of the bilharzial and non-bilharzial urinary bladder: a review of etiological features, natural history, and management.

El-Sebaie M, Zaghloul MS, Howard G, Mokhtar A.

Int J Clin Oncol. 2005 Feb;10(1):20-5. Review.

PMID:
15729596
11.

A prognostic index (bladder prognostic index) for bilharzial-related invasive bladder cancer.

Khaled H, El Hattab O, Moneim DA, Kassem HA, Morsi A, Sherif G, Darwish T, Gaafar R.

Urol Oncol. 2005 Jul-Aug;23(4):254-60.

PMID:
16018940
12.

Superficial (pT2a) and deep (pT2b) muscle invasion in pathological staging of bladder cancer following radical cystectomy.

Yu RJ, Stein JP, Cai J, Miranda G, Groshen S, Skinner DG.

J Urol. 2006 Aug;176(2):493-8; discussion 498-9.

PMID:
16813876
14.

Local control of muscle-invasive bladder cancer: preoperative radiotherapy and cystectomy versus cystectomy alone.

Cole CJ, Pollack A, Zagars GK, Dinney CP, Swanson DA, von Eschenbach AC.

Int J Radiat Oncol Biol Phys. 1995 May 15;32(2):331-40.

PMID:
7751174
15.
16.

External beam radiation therapy followed by interstitial radiotherapy with iridium-192 for solitary bladder tumours: results of 111 treated patients.

van Onna IE, Oddens JR, Kok ET, van Moorselaar RJ, Bosch JL, Battermann JJ.

Eur Urol. 2009 Jul;56(1):113-21. doi: 10.1016/j.eururo.2008.07.043. Epub 2008 Aug 21.

PMID:
18722048
17.

Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.

Karakiewicz PI, Shariat SF, Palapattu GS, Gilad AE, Lotan Y, Rogers CG, Vazina A, Gupta A, Bastian PJ, Perrotte P, Sagalowsky AI, Schoenberg M, Lerner SP.

J Urol. 2006 Oct;176(4 Pt 1):1354-61; discussion 1361-2.

PMID:
16952631
18.

Expression of CD44 protein in bilharzial and non-bilharzial bladder cancers.

Gadalla HA, Kamel NA, Badary FA, Elanany FG.

BJU Int. 2004 Jan;93(1):151-5.

PMID:
14678388
19.

Bcl-xL protein: predictor of complete tumor response in patients with oral cancer treated with curative radiotherapy.

Mallick S, Agarwal J, Kannan S, Pawar S, Kane S, Teni T.

Head Neck. 2013 Oct;35(10):1448-53. doi: 10.1002/hed.23153. Epub 2012 Sep 18.

PMID:
22987535
20.

Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.

Anticancer Res. 2002 Nov-Dec;22(6B):3759-64.

PMID:
12552989

Supplemental Content

Support Center